BHST (BioHarvest Sciences) Short-Term Debt to Capital

Corporate company logo of BioHarvest Sciences (BHST)

The price action of BioHarvest Sciences (BHST) on the GURU.Markets platform, where the indicator stands at 0.26, is driven by the synergy of a cohesive team of plant cell biology experts. BioHarvest Sciences (BHST) is actively expanding the production of pure components for nutraceuticals and medicine through an innovative cultivation method. The business minimizes risks by diversifying profit streams across the cosmetics, pharmaceuticals, and health food markets.

Ratio of Short-Term Indebtedness to Capital: BioHarvest (BHST) for 11/13/2024 - 10/31/2026

Analytical breakdowns for BioHarvest Sciences

- stock quotes and analyst forecast:
Stock Price BioHarvest|BHST - Fair Value Consensus
- business market valuation indicators:
Market Capitalization BioHarvest Sciences, Inc.|BHST - Enterprise Value
- book capitalization information:
Net Assets per Single Share BioHarvest Sciences|BHST - Accounting Value of Company|Market Value to Book Value Ratio bioharvest.com|BHST - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital BioHarvest Sciences|BHST - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio BioHarvest Sciences Inc.|BHST - Aggregate Debt Obligations|Debt to Book Capitalization Ratio BioHarvest Sciences, Inc.|BHST - Long-Term Debt|Company Current Liabilities BioHarvest Sciences|Quick Ratio bioharvest.com
- company profitability and valuation multiples indicators:
BHST - Final Profit
Fundamental valuation:BHST BioHarvest
Brand item of BioHarvest Sciences, Inc.

An investment audit of the issuer requires a thorough review of the debt load prior to asset acquisition. This ratio is calculated as the relationship between liabilities maturing within one year and total equity, measuring liquidity risk. For BioHarvest Sciences (BHST), with its stable revenue from bio-growth patents, this balance is critical for scaling production. This trend is clearly illustrated on this chart of the short-term debt-to-equity ratio.

Competitors of BioHarvest Sciences (BHST)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital EXOZ (eXoZymes)|Oramed - Short-Term Debt to Equity|Entera Bio Corp - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient MindWalk Therapeutics HYFT|ABVC BioPharma (ABVC) - Short-Term Debt to Equity|Current Liabilities to Capital cumberlandpharma.com (CPIX)|QNTM (Quantum BioPharma) - Short-Term Debt to Capital|FGEN: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TELO|Short-Term Debt to Capital ranitherapeutics.com (RANI)|Short-Term Debt to Equity Synergy CHC SNYR|Ratio of Short-Term Indebtedness to Capital RLYB|LEXX: Short-Term Debt to Equity Ratio|PULM: Short-Term Debt to Equity|PTHL: Short-Term Debt to Capital|Current Liabilities to Capital Aptorum Group (APM)|Short-Term Debt to Equity Lyra Therapeutics, Inc.|impactbiomedinc.com (IBO) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio TNFA (TNF Pharmaceuticals)|Short-Term Loans to Capital Ratio YCBD|PainReform Limited - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CYTO|LIPO - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient optinose.com OPTN|PIRS: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Procaps Group|PTPI (Petros) - Short-Term Debt to Capital|Qilian International Corp (QLI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SLRN|TFFP - Current Liabilities to Capital